Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-0.13/0.95
|
|
Enterprise Value
11.21B
|
| Balance Sheet |
|
Book Value Per Share
8.17
|
| Cash Flow |
|
Cash Flow Yield
0.08
|
| Income Statement |
|
Total Revenue
6.78B
|
|
Operating Revenue Per Share
10.32
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/11/15 00:20 EST
Industry overview quotes are at least 15 minutes delayed
|
Business Description
|
|||
| Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, andAMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |

11.38 
